PP01.47: PD-(L)1 Inhibitor Monotherapy Versus Chemo-Immunotherapy for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression ≥50%: A Systematic Review and Meta-Analysis with Individual Patient Data
Year: 2026
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: Alessandro Di Federico, Samuele Compagno, Francesco Mantuano, Sara Stumpo, Andrea De Giglio, Federica Pecci, Joao V. Alessi, Xinan Wang, Francesca Sperandi, Barbara Melotti, Francesco Gelsomino, Maria A. Pantaleo, Andrea Arfè, Hossein Borghaei, Marina C. Garassino, Federico Cappuzzo, Andrea Ardizzoni, Mark M. Awad, Biagio Ricciuti
Institutions: Dana-Farber Cancer Institute, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, University of Parma, Hospital Sírio-Libanês, Harvard University, Memorial Sloan Kettering Cancer Center, Fox Chase Cancer Center, University of Chicago, Instituto Nazionale Tumori Regina Elena
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7167222069